Kyung-Hoi Cha

Title: Innovator Kyung-Hoi Cha: Pioneering Advances in Sustained-Release Formulations

Introduction

Kyung-Hoi Cha is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly with his innovative approaches to drug formulation. With a total of two patents to his name, his work highlights the intersection of technology and healthcare.

Latest Patents

Kyung-Hoi Cha's latest patents include groundbreaking methods that improve the delivery and efficacy of pharmaceutical products.

1. **Preparation Method of Sustained-Release Microcapsules Having Initial Burst Inhibiting Property**: This patent discloses an advanced method for preparing longer sustained-release formulations containing bioactive substances. The innovative process involves adding an emulsion consisting of bioactive substances, a biocompatible polymer, and polyvinylpyrrolidone to an aqueous solution, enabling a more effective delivery system for various medications.

2. **Method of Producing Teicoplanin**: This patent presents a novel approach to producing teicoplanin, an important antibiotic. The method covers purifying teicoplanin from a culture broth, which has been obtained by culturing microorganisms that produce this compound. Purification is achieved through a porous adsorption resin under selective elution conditions, followed by the recovery of highly pure teicoplanin using activated carbon and/or ultrafiltration. Ultrafiltration is also mentioned as a pre-treatment step to enhance the purity of the final product.

Career Highlights

Kyung-Hoi Cha is affiliated with Dongkook Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His dedication to research and development showcases his commitment to enhancing drug delivery systems and ensuring effective treatments for patients.

Collaborations

Throughout his career, Kyung-Hoi Cha has worked closely with esteemed colleagues, including Deok-Joong Youn and Ho-Myeung Ryu. These collaborations have been instrumental in furthering the scope and impact of his inventions in pharmaceutical technology.

Conclusion

Kyung-Hoi Cha stands out as an inventor committed to advancing pharmaceutical innovations through his patented methods. His work not only contributes to improved patient outcomes but also serves as a benchmark for future research in the field. As he continues his journey at Dongkook Pharmaceutical Co., Ltd., the pharmaceutical community anticipates further contributions that may shape the future of drug delivery systems.